Description
BUY ARA-290 NASAL PEPTIDE SPRAY
This product is intended for research and medical purposes only, to be only used by trained professionals.
ARA-290 nasal is a short peptide generated from the beta-helix of erythropoietin (EPO). It has been known for some time that EPO has other effects besides boosting the generation of red blood cells in the bone marrow.
In diabetic neuropathy, glycoprotein, a kidney-produced protein, has been demonstrated to improve cell survival, stimulate the growth of blood vessels, and modify blood pressure.
As an EPO neuroprotectant and analgesic, ARA-290 does not enhance red blood cell formation.
According to studies, ARA-290 could be tested. In addition, the peptide’s ability to alleviate neuropathic pain is currently being studied.
It is also being investigated as a potential wound-healing stimulant, immunological modulator, and systemic lupus erythematosus (SLE) therapy.
REFERENCES:
1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883966/
2. https://molmed.biomedcentral.com/articles/10.2119/molmed.2012.00332
Molecular Formula: C51H84N16O21
Sequence: XEQLERALNSS
Storage: Lyophilized peptides stored below -18°C.
Research use only. Not for human or animal consumption!
DISCLAIMER: We do not supply peptides to any individual under the age of 21. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY in the process of laboratory research by responsible trained and professional individuals. All products listed on this website (https://direct-peptides.com) and provided through Direct Peptides are intended for laboratory research purposes only. The products listed on this website are NOT for human or animal consumption or ingestion of any kind.
